# OnCo record differentiation-syndrome-recognition-and-treatment (protocol). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/protocols/differentiation-syndrome-recognition-and-treatment/>
  a schema:MedicalGuideline ;
  onco:kind "protocol" ;
  schema:identifier "differentiation-syndrome-recognition-and-treatment" ;
  schema:name "Differentiation syndrome on IDH, FLT3 and menin inhibitors and on tretinoin or arsenic trioxide: recognition and treatment"@en ;
  schema:alternateName "differentiation syndrome"@en, "DS"@en, "retinoic acid syndrome"@en, "ATRA syndrome"@en, "IDH differentiation syndrome"@en, "IDH-DS"@en, "menin inhibitor differentiation syndrome"@en, "APL differentiation syndrome"@en, "dexamethasone 10 mg twice daily for differentiation syndrome"@en ;
  schema:description "Some leukaemia medicines work by making leukaemia cells mature. This can cause fever, breathlessness, fluid on the lungs, sudden weight gain, swelling, low blood pressure or kidney problems. This is differentiation syndrome. It is treated at once with a steroid such as dexamethasone and can be fatal if not treated. Call your team or go to the nearest emergency department right away."@en ;
  schema:url <https://onco.cc/protocols/differentiation-syndrome-recognition-and-treatment/> ;
  schema:dateModified "2026-11-17"^^xsd:date ;
  onco:related <https://onco.cc/protocols/tumour-lysis-syndrome-prevention-and-treatment/>, <https://onco.cc/protocols/hyperleukocytosis-leukostasis/>, <https://onco.cc/protocols/capillary-leak-syndrome-on-anticancer-drugs/>, <https://onco.cc/protocols/febrile-neutropenia-first-hour/>, <https://onco.cc/drugs/dexamethasone/>, <https://onco.cc/drugs/hydroxyurea/> ;
  onco:drugs <https://onco.cc/drugs/ivosidenib/>, <https://onco.cc/drugs/enasidenib/>, <https://onco.cc/drugs/olutasidenib/>, <https://onco.cc/drugs/gilteritinib/>, <https://onco.cc/drugs/revumenib/>, <https://onco.cc/drugs/ziftomenib/>, <https://onco.cc/drugs/tretinoin-atra/>, <https://onco.cc/drugs/arsenic-trioxide/> ;
  onco:terms <https://onco.cc/terms/differentiation-syndrome/>, <https://onco.cc/terms/tumor-lysis-syndrome/> .
